214 related articles for article (PubMed ID: 20203166)
1. The FDA's perspective on the risk for rapid rise in hemoglobin in treating CKD anemia: Quo Vadis.
Singh AK
Clin J Am Soc Nephrol; 2010 Apr; 5(4):553-6. PubMed ID: 20203166
[No Abstract] [Full Text] [Related]
2. Against TREATing all patients alike: lessons from an FDA Advisory Committee Meeting.
Winkelmayer WC
J Am Soc Nephrol; 2011 Jan; 22(1):1-2. PubMed ID: 21164031
[No Abstract] [Full Text] [Related]
3. Individualizing decision-making--resurrecting the doctor-patient relationship in the anemia debate.
Agarwal R
Clin J Am Soc Nephrol; 2010 Jul; 5(7):1340-6. PubMed ID: 20448071
[TBL] [Abstract][Full Text] [Related]
4. Erythropoietic stimulating agents and quality of a patient's life: individualizing anemia treatment.
Kliger AS; Fishbane S; Finkelstein FO
Clin J Am Soc Nephrol; 2012 Feb; 7(2):354-7. PubMed ID: 22266571
[TBL] [Abstract][Full Text] [Related]
5. Does TREAT give the boot to ESAs in the treatment of CKD anemia?
Singh AK
J Am Soc Nephrol; 2010 Jan; 21(1):2-6. PubMed ID: 20035034
[No Abstract] [Full Text] [Related]
6. The new FDA labeling for ESA--implications for patients and providers.
Manns BJ; Tonelli M
Clin J Am Soc Nephrol; 2012 Feb; 7(2):348-53. PubMed ID: 22266575
[TBL] [Abstract][Full Text] [Related]
7. Triumph and tragedy: anemia management in chronic kidney disease.
Novak JE; Szczech LA
Curr Opin Nephrol Hypertens; 2008 Nov; 17(6):580-8. PubMed ID: 18941350
[TBL] [Abstract][Full Text] [Related]
8. Editorial perspective. Should hemoglobin targets for anemic patients with chronic kidney disease be changed?
Parfrey PS
Am J Nephrol; 2010; 31(6):565-6. PubMed ID: 20501992
[No Abstract] [Full Text] [Related]
9. The CARI guidelines. Biochemical and haematological targets. Haemoglobin.
McMahon L;
Nephrology (Carlton); 2008 Jul; 13 Suppl 2():S44-56. PubMed ID: 18713123
[No Abstract] [Full Text] [Related]
10. Erythropoiesis-stimulating agents in cancer.
Arcasoy MO
J Clin Oncol; 2008 Jun; 26(18):3097-8; author reply 3098-100. PubMed ID: 18565902
[No Abstract] [Full Text] [Related]
11. It's time to compare anemia management strategies in hemodialysis.
Coyne DW
Clin J Am Soc Nephrol; 2010 Apr; 5(4):740-2. PubMed ID: 20299363
[TBL] [Abstract][Full Text] [Related]
12. Are there implications from the Trial to Reduce Cardiovascular Events with Aranesp Therapy study for anemia management in dialysis patients?
Berns JS
Curr Opin Nephrol Hypertens; 2010 Nov; 19(6):567-72. PubMed ID: 20601876
[TBL] [Abstract][Full Text] [Related]
13. Applying evidence into routine clinical care at a unit level: the exemplar of renal anaemia management.
Gallagher MP; Cass A; Craig JC
Nephrology (Carlton); 2010 Jun; 15(4):429-33. PubMed ID: 20609094
[TBL] [Abstract][Full Text] [Related]
14. [Anemia: guidelines comparison].
Del Vecchio L
G Ital Nefrol; 2009; 26(6):686-94. PubMed ID: 19918751
[TBL] [Abstract][Full Text] [Related]
15. [Regarding the optimal hemoglobin target range in renal anemia].
Maurin N
Med Klin (Munich); 2008 Sep; 103(9):633-7. PubMed ID: 18813886
[TBL] [Abstract][Full Text] [Related]
16. Message to the FDA on ESAs: REMS is not enough, more studies are needed.
Singh AK
Clin J Am Soc Nephrol; 2010 Aug; 5(8):1355-8. PubMed ID: 20688885
[No Abstract] [Full Text] [Related]
17. The treatment of anemia in chronic kidney disease: understandings in 2006.
Levin A
Curr Opin Nephrol Hypertens; 2007 May; 16(3):267-71. PubMed ID: 17420672
[TBL] [Abstract][Full Text] [Related]
18. [Should we modify hemoglobin targets in CKD patients? FDA and EMEA statements].
Martín de Francisco AL; Aljama P; Arias M; Górriz JL; Martínez Castelao A; Portolés J
Nefrologia; 2007; 27(4):399-404. PubMed ID: 17944575
[No Abstract] [Full Text] [Related]
19. The controversy surrounding hemoglobin and erythropoiesis-stimulating agents: what should we do now?
Singh AK
Am J Kidney Dis; 2008 Dec; 52(6 Suppl):S5-13. PubMed ID: 19010260
[TBL] [Abstract][Full Text] [Related]
20. Debate: PRO Position. Should hemoglobin targets for anemic patients with chronic kidney disease be changed?
Singh AK
Am J Nephrol; 2010; 31(6):552-6; discussion 563-4. PubMed ID: 20501988
[No Abstract] [Full Text] [Related]
[Next] [New Search]
